Stay updated on Pediatric LDX Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Pediatric LDX Safety & Efficacy Clinical Trial page.
Latest updates to the Pediatric LDX Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check46 days agoChange DetectedA new study on the efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD has been added, while several previous studies on the same topic have been removed.SummaryDifference12%
- Check53 days agoChange DetectedSeveral links to genetic and medication information, including those related to ADHD and specific drugs, have been removed, along with various data fields and options for downloading study information.SummaryDifference4%
- Check60 days agoChange DetectedNew resources related to genetics and ADHD medications have been added, including links to MedlinePlus, DailyMed, and PubMed, enhancing access to important health information.SummaryDifference0.5%
Stay in the know with updates to Pediatric LDX Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric LDX Safety & Efficacy Clinical Trial page.